Tech Company Financing Transactions
MicroPhage Funding Round
Private investors participated in a $11 million funding round for MicroPhage. The round was announced by the company on 11/20/2008.
Transaction Overview
Company Name
Announced On
11/20/2008
Transaction Type
Venture Equity
Amount
$11,000,000
Round
Undisclosed
Investors
Proceeds Purpose
MicroPhage will apply proceeds of its financing to complete the validation and launch preparation of their initial diagnostic products, which address the growing need for simple, rapid and highly accurate tests for hospital-acquired infections (HAIs), such as MRSA.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2400 Trade Centre Ave.
Longmont, CO 80503
USA
Longmont, CO 80503
USA
Phone
Website
Email Address
Not Recorded
Overview
MicroPhage's mission is to be a worldwide leader in rapid bacterial diagnostics, in both bacterial identification and antibiotic susceptibility / resistance testing, through its bacteriophage-based amplification platform for immunoassay diagnostics. The company will develop, manufacture, and market these tests into the clinical market.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Don Mooney
Chief Scientific Officer
Drew Smith
VP - Manufacturing
Preston Brown
VP - Sales
Brian MacDonald
Browse more venture capital transactions:
Prev: 11/19/2008: Knopp Biosciences venture capital transaction
Next: 11/20/2008: Real Girls Media Network venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs